Rapid removal of vancomycin by continuous veno-venous hemofiltration

被引:6
|
作者
Shah, M [1 ]
Quigley, R [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75237 USA
关键词
vancomycin; acute renal failure; continuous veno-venous hemofiltration nephrotoxicity;
D O I
10.1007/s004670000317
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We describe a 14-year-old girl with staphylococcal (coagulase-negative) ventriculo-peritoneal shunt infection, who developed oliguric acute renal failure and was found to have a serum vancomycin concentration of 250 mu g/ml. Since only about 10%-50% of vancomycin is bound to protein in blood, we employed continuous veno-venous hemofiltration (CVVH) with a high ultrafiltration rate (1,800 ml/h) for increased convective clearance to remove vancomycin, which may have contributed to the acute renal failure. At the end of 38 h of CVVH, the vancomycin concentration had decreased in an exponential manner to 27 mu g/ml. Over the subsequent 3-4 days, her renal function improved and the vancomycin concentration decreased further to <5 mu g/ml. In conclusion, we believe that a high serum vancomycin concentration may be nephrotoxic and demonstrate that CVVH can be used effectively to remove vancomycin in children with acute renal failure.
引用
收藏
页码:912 / 915
页数:4
相关论文
共 50 条
  • [21] Impact of continuous veno-venous hemofiltration on acid-base balance
    Bellomo, R. (rinaldo.bellomo@armc.org.au), 1600, Wichtig Editore s.r.l. (26):
  • [22] Thermal energy balance during in vitro continuous veno-venous hemofiltration
    Manns, Markus
    Maurer, Erik
    Steinbach, Bernd
    Evering, Hans-Gerd
    ASAIO Journal, 44 (05):
  • [23] Impact of continuous veno-venous hemofiltration on acid-base balance
    Rocktäschel, J
    Morimatsu, H
    Uchino, S
    Ronco, C
    Bellomo, R
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2003, 26 (01): : 19 - 25
  • [24] Therapeutic drug monitoring of imipenem during continuous veno-venous hemofiltration
    Tegeder, I
    Bremer, F
    Oelkers, R
    Schuttler, J
    Brune, K
    Geisslinger, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 485 - 485
  • [25] CEFTOLOZANE-TAZOBACTAM PHARMACOKINETICS IN A PATIENT ON CONTINUOUS VENO-VENOUS HEMOFILTRATION
    Oliver, Wesley
    Gonzales, Jeffrey
    Heil, Emily
    Mehrotra, Shailly
    Robinett, Kathryn
    Saleeb, Paul
    Nicolau, David
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [26] A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration
    Egi, M
    Naka, T
    Bellomo, R
    Cole, L
    French, C
    Trethewy, C
    Wan, L
    Langenberg, CC
    Fealy, N
    Baldwin, I
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2005, 28 (12): : 1211 - 1218
  • [27] Effectiveness of continuous veno-venous hemofiltration in the treatment of severe acute pancreatitis
    Chen, Xuan
    Sun, Meifang
    Mao, Xiuhong
    Liu, Xiaoxia
    Sun, Weihe
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (04) : 2720 - 2724
  • [28] Myoglobin clearance during continuous veno-venous hemofiltration with or without dialysis
    Nicolau, D
    Feng, YS
    Wu, AHB
    Bernstein, SP
    Nightingale, CH
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1998, 21 (04): : 205 - 209
  • [29] PREDICTORS OF IN HOSPITAL MORTALITY IN PATIENTS ON CONTINUOUS VENO-VENOUS HEMOFILTRATION IN THE ICU
    Saqib, Amina
    Siddiqui, Abulhasan
    Jawalant, Modi
    Raja, MAsood
    El Sayegh, Suzanne
    Maniatis, Theodore
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [30] Teicoplanin pharmacokinetics in critically ill patients on continuous veno-venous hemofiltration
    Bellmann, R.
    Falkensammer, G.
    Seger, C.
    Weiler, S.
    Kountchev, J.
    Joannidis, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (04) : 243 - 249